NEW class of pain relievers

There's a lot of interest in a NEW class of painrelievers...COX-2 specific inhibitors.

Searle's Celebra (celecoxib) will be first...with Merck'sVioxx close behind...and others following.

These will be BIG.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote